Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: Correlations to symptomatology and family history

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

1963 • 2,148 citations

Molecular pathology of schizophrenia: more than one disease process?

1980 • 1,877 citations

5-HIAA in the Cerebrospinal Fluid

1976 • 1,430 citations

Drugs, Neurotransmitters, and Schizophrenia

1974 • 832 citations

Monoamine Metabolites in CSF and Suicidal Behavior

1981 • 692 citations

INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA

1978 • 513 citations

NOSIE-30: A Treatment-Sensitive Ward Behavior Scale

1966 • 357 citations

Central Dopamine Turnover in Schizophrenic Syndromes

1974 • 268 citations

Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitro

1978 • 261 citations

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method

1976 • 229 citations

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

1975 • 202 citations

3H-flupenthixol binding in post-mortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors

1981 • 165 citations

CSF monoamine metabolites in depression and schizophrenia

1980 • 165 citations

Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex

1971 • 160 citations

Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders

1975 • 140 citations

The Dopamine Hypothesis: An Overview of Studies With Schizophrenic Patients

1982 • 126 citations

Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients

1977 • 101 citations

5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines

1973 • 98 citations

Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic Schizophrenics

1969 • 97 citations

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

1983 • 96 citations

Depression vulnerability and 5-hydroxytryptophan prophylaxis

1980 • 95 citations

Aberrant Monoamine Metabolite Levels in CSF and Family History of Schizophrenia

1980 • 94 citations

Life at risk: markers of suicidality in depression.

1983 • 89 citations

Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process

1978 • 85 citations

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders

1970 • 83 citations

On the origin of homovanillic acid (HVA) in the cerebrospinal fluid

1973 • 69 citations

The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia

1971 • 61 citations

Mass fragmentometric determination of homovanillic acid in lumbar cerebro-spinal fluid of schizophrenic patients during treatment with antipsychotic drugs

1974 • 60 citations

CSF monoamine metabolites in schizophrenic patients

1982 • 56 citations

Amphetamine Psychosis

1957 • 54 citations

Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients

1983 • 47 citations

MONOAMINE METABOLITES IN CEREBROSPINAL FLUID IN RELATION TO DEPRESSIVE ILLNESS, SUICIDAL BEHAVIOUR AND PERSONALITY

1981 • 43 citations

Biological markers in major depressive disorders : a clinical and multivariate study

1981 • 28 citations

Dopamine in thelimbic regions of the human brain: normal and abnormal.

1977 • 27 citations